Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 222

1.

Phenotypic Features of Oguchi Disease and Retinitis Pigmentosa in Patients with S-Antigen Mutations: A Long-Term Follow-up Study.

Nishiguchi KM, Ikeda Y, Fujita K, Kunikata H, Akiho M, Hashimoto K, Hosono K, Kurata K, Koyanagi Y, Akiyama M, Suzuki T, Kawasaki R, Wada Y, Hotta Y, Sonoda KH, Murakami A, Nakazawa M, Nakazawa T, Abe T.

Ophthalmology. 2019 Jun 6. pii: S0161-6420(19)30725-0. doi: 10.1016/j.ophtha.2019.05.027. [Epub ahead of print]

PMID:
31257036
2.

A frequent variant in the Japanese population determines quasi-Mendelian inheritance of rare retinal ciliopathy.

Nikopoulos K, Cisarova K, Quinodoz M, Koskiniemi-Kuendig H, Miyake N, Farinelli P, Rehman AU, Khan MI, Prunotto A, Akiyama M, Kamatani Y, Terao C, Miya F, Ikeda Y, Ueno S, Fuse N, Murakami A, Wada Y, Terasaki H, Sonoda KH, Ishibashi T, Kubo M, Cremers FPM, Kutalik Z, Matsumoto N, Nishiguchi KM, Nakazawa T, Rivolta C.

Nat Commun. 2019 Jun 28;10(1):2884. doi: 10.1038/s41467-019-10746-4.

3.

Quantitative analysis of the macula with optical coherence tomography angiography in normal Japanese subjects: The Taiwa Study.

Sato R, Kunikata H, Asano T, Aizawa N, Kiyota N, Shiga Y, Nishiguchi KM, Kato K, Nakazawa T.

Sci Rep. 2019 Jun 20;9(1):8875. doi: 10.1038/s41598-019-45336-3.

4.

Genetic characteristics of retinitis pigmentosa in 1204 Japanese patients.

Koyanagi Y, Akiyama M, Nishiguchi KM, Momozawa Y, Kamatani Y, Takata S, Inai C, Iwasaki Y, Kumano M, Murakami Y, Omodaka K, Abe T, Komori S, Gao D, Hirakata T, Kurata K, Hosono K, Ueno S, Hotta Y, Murakami A, Terasaki H, Wada Y, Nakazawa T, Ishibashi T, Ikeda Y, Kubo M, Sonoda KH.

J Med Genet. 2019 Oct;56(10):662-670. doi: 10.1136/jmedgenet-2018-105691. Epub 2019 Jun 17.

PMID:
31213501
5.

Synergistic Effects of Olaparib and DNA-damaging Agents in Oesophageal Squamous Cell Carcinoma Cell Lines.

Miyamoto K, Minegaki T, Tanahashi M, Yamamoto A, Moriyama Y, Wada A, Matsumoto A, Ota K, Tanaka M, Masuda U, Tsujimoto M, Nishiguchi K.

Anticancer Res. 2019 Apr;39(4):1813-1820. doi: 10.21873/anticanres.13288.

PMID:
30952721
6.

Macular Dystrophy and Cone-Rod Dystrophy Caused by Mutations in the RP1 Gene: Extending the RP1 Disease Spectrum.

Verbakel SK, van Huet RAC, den Hollander AI, Geerlings MJ, Kersten E, Klevering BJ, Klaver CCW, Plomp AS, Wesseling NL, Bergen AAB, Nikopoulos K, Rivolta C, Ikeda Y, Sonoda KH, Wada Y, Boon CJF, Nakazawa T, Hoyng CB, Nishiguchi KM.

Invest Ophthalmol Vis Sci. 2019 Mar 1;60(4):1192-1203. doi: 10.1167/iovs.18-26084.

PMID:
30913292
7.

Macular degeneration as a common cause of visual loss in spinocerebellar ataxia type 1 (SCA1) patients.

Nishiguchi KM, Aoki M, Nakazawa T, Abe T.

Ophthalmic Genet. 2019 Feb;40(1):49-53. doi: 10.1080/13816810.2019.1571614. Epub 2019 Feb 7.

PMID:
30729852
8.

Reliable detection of low visual acuity in mice with pattern visually evoked potentials.

Tokashiki N, Nishiguchi KM, Fujita K, Sato K, Nakagawa Y, Nakazawa T.

Sci Rep. 2018 Oct 29;8(1):15948. doi: 10.1038/s41598-018-34413-8.

9.

Histone deacetylase inhibitors sensitize 5-fluorouracil-resistant MDA-MB-468 breast cancer cells to 5-fluorouracil.

Minegaki T, Suzuki A, Mori M, Tsuji S, Yamamoto S, Watanabe A, Tsuzuki T, Tsunoda T, Yamamoto A, Tsujimoto M, Nishiguchi K.

Oncol Lett. 2018 Nov;16(5):6202-6208. doi: 10.3892/ol.2018.9388. Epub 2018 Sep 4.

10.

Effects of Uremic Serum Residue on OATP1B1- and OATP1B3-Mediated Pravastatin Uptake in OATP-Expressing HEK293 Cells and Human Hepatocytes.

Uchiyama H, Tsujimoto M, Kimura A, Yuki E, Saiki T, Yoshida T, Furukubo T, Izumi S, Yamakawa T, Tachiki H, Minegaki T, Nishiguchi K.

Ther Apher Dial. 2019 Apr;23(2):126-132. doi: 10.1111/1744-9987.12758. Epub 2018 Oct 14.

PMID:
30318712
11.

Metabolomic changes in the mouse retina after optic nerve injury.

Sato K, Saigusa D, Saito R, Fujioka A, Nakagawa Y, Nishiguchi KM, Kokubun T, Motoike IN, Maruyama K, Omodaka K, Shiga Y, Uruno A, Koshiba S, Yamamoto M, Nakazawa T.

Sci Rep. 2018 Aug 9;8(1):11930. doi: 10.1038/s41598-018-30464-z.

12.

Ecel1 Knockdown With an AAV2-Mediated CRISPR/Cas9 System Promotes Optic Nerve Damage-Induced RGC Death in the Mouse Retina.

Sato K, Shiga Y, Nakagawa Y, Fujita K, Nishiguchi KM, Tawarayama H, Murayama N, Maekawa S, Yabana T, Omodaka K, Katayama S, Feng Q, Tsuda S, Nakazawa T.

Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):3943-3951. doi: 10.1167/iovs.18-23784.

PMID:
30073365
13.

Retained Plasticity and Substantial Recovery of Rod-Mediated Visual Acuity at the Visual Cortex in Blind Adult Mice with Retinal Dystrophy.

Nishiguchi KM, Fujita K, Tokashiki N, Komamura H, Takemoto-Kimura S, Okuno H, Bito H, Nakazawa T.

Mol Ther. 2018 Oct 3;26(10):2397-2406. doi: 10.1016/j.ymthe.2018.07.012. Epub 2018 Jul 17.

14.

Alternative methods to detect anti-TRPM1 antibodies.

Nishiguchi KM, Fujita K, Inoue T, Nakazawa T.

Clin Exp Ophthalmol. 2019 Jan;47(1):148-149. doi: 10.1111/ceo.13365. Epub 2018 Aug 14. No abstract available.

PMID:
30047207
15.

Quantitative MRI evaluation of glaucomatous changes in the visual pathway.

Fukuda M, Omodaka K, Tatewaki Y, Himori N, Matsudaira I, Nishiguchi KM, Murata T, Taki Y, Nakazawa T.

PLoS One. 2018 Jul 9;13(7):e0197027. doi: 10.1371/journal.pone.0197027. eCollection 2018.

16.

Anti-TRPM1 antibodies in patients with retinal degeneration.

Nishiguchi KM, Fujita K, Inoue T, Nakazawa T.

Clin Exp Ophthalmol. 2018 Dec;46(9):1087-1089. doi: 10.1111/ceo.13341. Epub 2018 Jul 1. No abstract available.

PMID:
29927037
17.
18.

Correlation between aqueous flare and residual visual field area in retinitis pigmentosa.

Nishiguchi KM, Yokoyama Y, Kunikata H, Abe T, Nakazawa T.

Br J Ophthalmol. 2019 Apr;103(4):475-480. doi: 10.1136/bjophthalmol-2018-312225. Epub 2018 Jun 1.

PMID:
29858180
19.

Concomitant administration of candesartan cilexetil in patients on paclitaxel and carboplatin combination therapy increases risk of severe neutropenia
.

Katsube Y, Hira D, Tsujimoto M, Koide H, Minegaki T, Ikeda Y, Morita SY, Nishiguchi K, Terada T.

Int J Clin Pharmacol Ther. 2018 Jul;56(7):328-336. doi: 10.5414/CP203180.

PMID:
29792394
20.

Augmentation of the cytotoxic effects of nitrogen-containing bisphosphonates in hypoxia.

Minegaki T, Koiki S, Douke Y, Yamane C, Suzuki A, Mori M, Tsujimoto M, Nishiguchi K.

J Pharm Pharmacol. 2018 Aug;70(8):1040-1047. doi: 10.1111/jphp.12934. Epub 2018 May 15.

PMID:
29761837
21.

Acceleration of carboxylesterase-mediated activation of irinotecan to SN-38 by serum from patients with end-stage kidney disease.

Koide H, Tsujimoto M, Katsube Y, Ochiai M, Hojo A, Furukubo T, Izumi S, Yamakawa T, Shima D, Minegaki T, Nishiguchi K.

Cancer Chemother Pharmacol. 2018 Jun;81(6):1121-1128. doi: 10.1007/s00280-018-3583-y. Epub 2018 Apr 24.

PMID:
29693202
22.

Levels of Anti-Retinal Antibodies in Retinal Detachment and Proliferative Vitreoretinopathy.

Ichinohasama R, Nishiguchi KM, Fujita K, Aizawa N, Inoue T, Sasaki E, Kunikata H, Nakazawa T.

Curr Eye Res. 2018 Jun;43(6):804-809. doi: 10.1080/02713683.2018.1451544. Epub 2018 Mar 16.

PMID:
29547015
23.

Assessment of inhalation flow patterns of soft mist inhaler co-prescribed with dry powder inhaler using inspiratory flow meter for multi inhalation devices.

Hira D, Koide H, Nakamura S, Okada T, Ishizeki K, Yamaguchi M, Koshiyama S, Oguma T, Ito K, Funayama S, Komase Y, Morita SY, Nishiguchi K, Nakano Y, Terada T.

PLoS One. 2018 Feb 20;13(2):e0193082. doi: 10.1371/journal.pone.0193082. eCollection 2018.

24.

Genome-wide association study identifies seven novel susceptibility loci for primary open-angle glaucoma.

Shiga Y, Akiyama M, Nishiguchi KM, Sato K, Shimozawa N, Takahashi A, Momozawa Y, Hirata M, Matsuda K, Yamaji T, Iwasaki M, Tsugane S, Oze I, Mikami H, Naito M, Wakai K, Yoshikawa M, Miyake M, Yamashiro K; Japan Glaucoma Society Omics Group (JGS-OG), Kashiwagi K, Iwata T, Mabuchi F, Takamoto M, Ozaki M, Kawase K, Aihara M, Araie M, Yamamoto T, Kiuchi Y, Nakamura M, Ikeda Y, Sonoda KH, Ishibashi T, Nitta K, Iwase A, Shirato S, Oka Y, Satoh M, Sasaki M, Fuse N, Suzuki Y, Cheng CY, Khor CC, Baskaran M, Perera S, Aung T, Vithana EN, Cooke Bailey JN, Kang JH, Pasquale LR, Haines JL; NEIGHBORHOOD Consortium, Wiggs JL, Burdon KP, Gharahkhani P, Hewitt AW, Mackey DA, MacGregor S, Craig JE, Allingham RR, Hauser M, Ashaye A, Budenz DL, Akafo S, Williams SEI, Kamatani Y, Nakazawa T, Kubo M.

Hum Mol Genet. 2018 Apr 15;27(8):1486-1496. doi: 10.1093/hmg/ddy053.

25.

Discovery of a Cynomolgus Monkey Family With Retinitis Pigmentosa.

Ikeda Y, Nishiguchi KM, Miya F, Shimozawa N, Funatsu J, Nakatake S, Fujiwara K, Tachibana T, Murakami Y, Hisatomi T, Yoshida S, Yasutomi Y, Tsunoda T, Nakazawa T, Ishibashi T, Sonoda KH.

Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):826-830. doi: 10.1167/iovs.17-22958.

PMID:
29411010
26.

Selective layer-free blood serum ionogram based on ion-specific interactions with a nanotransistor.

Sivakumarasamy R, Hartkamp R, Siboulet B, Dufrêche JF, Nishiguchi K, Fujiwara A, Clément N.

Nat Mater. 2018 May;17(5):464-470. doi: 10.1038/s41563-017-0016-y. Epub 2018 Feb 5.

PMID:
29403057
27.

Evaluation of Trace Elements in Augmentation of Statin-Induced Cytotoxicity in Uremic Serum-Exposed Human Rhabdomyosarcoma Cells.

Uchiyama H, Tsujimoto M, Shimada N, Tsutsui K, Nitta A, Yoshida T, Furukubo T, Izumi S, Yamakawa T, Tachiki H, Minegaki T, Nishiguchi K.

Toxins (Basel). 2018 Jan 25;10(2). pii: E53. doi: 10.3390/toxins10020053.

28.

Genetic analysis of Japanese primary open-angle glaucoma patients and clinical characterization of risk alleles near CDKN2B-AS1, SIX6 and GAS7.

Shiga Y, Nishiguchi KM, Kawai Y, Kojima K, Sato K, Fujita K, Takahashi M, Omodaka K, Araie M, Kashiwagi K, Aihara M, Iwata T, Mabuchi F, Takamoto M, Ozaki M, Kawase K, Fuse N, Yamamoto M, Yasuda J, Nagasaki M, Nakazawa T; Japan Glaucoma Society Omics Group (JGS-OG).

PLoS One. 2017 Dec 20;12(12):e0186678. doi: 10.1371/journal.pone.0186678. eCollection 2017.

29.

In situ regeneration of retinal pigment epithelium by gene transfer of E2F2: a potential strategy for treatment of macular degenerations.

Kampik D, Basche M, Luhmann UFO, Nishiguchi KM, Williams JAE, Greenwood J, Moss SE, Han H, Azam S, Duran Y, Robbie SJ, Bainbridge JWB, Larkin DF, Smith AJ, Ali RR.

Gene Ther. 2017 Dec;24(12):810-818. doi: 10.1038/gt.2017.89. Epub 2017 Nov 30.

PMID:
29188796
30.

Prevalence of anti-retinal antibodies in epiretinal membranes and macular holes.

Kunikata H, Fujita K, Nishiguchi KM, Nakazawa T.

Clin Exp Ophthalmol. 2018 Jul;46(5):556-558. doi: 10.1111/ceo.13099. Epub 2017 Dec 6. No abstract available.

PMID:
29135070
31.

Substrate-dependent effects of molecular-targeted anticancer agents on activity of organic anion transporting polypeptide 1B1.

Koide H, Tsujimoto M, Takeuchi A, Tanaka M, Ikegami Y, Tagami M, Abe S, Hashimoto M, Minegaki T, Nishiguchi K.

Xenobiotica. 2018 Oct;48(10):1059-1071. doi: 10.1080/00498254.2017.1393582. Epub 2017 Nov 10. Erratum in: Xenobiotica. 2018 Oct;48(10):x.

PMID:
29034773
32.

Inhibitory Effects of Juices Prepared from Individual Vegetables on CYP3A4 Activity in Recombinant CYP3A4 and LS180 Cells.

Tsujimoto M, Agawa C, Ueda S, Yamane T, Kitayama H, Terao A, Fukuda T, Minegaki T, Nishiguchi K.

Biol Pharm Bull. 2017;40(9):1561-1565. doi: 10.1248/bpb.b17-00116.

33.

Additive effects of genetic variants associated with intraocular pressure in primary open-angle glaucoma.

Mabuchi F, Mabuchi N, Sakurada Y, Yoneyama S, Kashiwagi K, Iijima H, Yamagata Z, Takamoto M, Aihara M, Iwata T, Kawase K, Shiga Y, Nishiguchi KM, Nakazawa T, Ozaki M, Araie M; Japan Glaucoma Society Omics Group (JGS-OG).

PLoS One. 2017 Aug 23;12(8):e0183709. doi: 10.1371/journal.pone.0183709. eCollection 2017.

34.

The neuroprotective effect of hesperidin in NMDA-induced retinal injury acts by suppressing oxidative stress and excessive calpain activation.

Maekawa S, Sato K, Fujita K, Daigaku R, Tawarayama H, Murayama N, Moritoh S, Yabana T, Shiga Y, Omodaka K, Maruyama K, Nishiguchi KM, Nakazawa T.

Sci Rep. 2017 Jul 31;7(1):6885. doi: 10.1038/s41598-017-06969-4.

35.

Power generator driven by Maxwell's demon.

Chida K, Desai S, Nishiguchi K, Fujiwara A.

Nat Commun. 2017 May 16;8:15310. doi: 10.1038/ncomms15301.

36.

Spatially and Temporally Regulated NRF2 Gene Therapy Using Mcp-1 Promoter in Retinal Ganglion Cell Injury.

Fujita K, Nishiguchi KM, Shiga Y, Nakazawa T.

Mol Ther Methods Clin Dev. 2017 Apr 19;5:130-141. doi: 10.1016/j.omtm.2017.04.003. eCollection 2017 Jun 16.

37.

Previous Dosage of Allopurinol Is a Strong Determinant of Febuxostat Efficacy.

Koide H, Hira D, Tsujimoto M, Katsube Y, Minegaki T, Uzu T, Ikeda Y, Morita SY, Nishiguchi K, Terada T.

Biol Pharm Bull. 2017;40(5):681-686. doi: 10.1248/bpb.b16-00972.

38.

Cooperative inhibitory effects of uremic toxins and other serum components on OATP1B1-mediated transport of SN-38.

Katsube Y, Tsujimoto M, Koide H, Ochiai M, Hojyo A, Ogawa K, Kambara K, Torii N, Shima D, Furukubo T, Izumi S, Yamakawa T, Minegaki T, Nishiguchi K.

Cancer Chemother Pharmacol. 2017 Apr;79(4):783-789. doi: 10.1007/s00280-017-3276-y. Epub 2017 Mar 17.

PMID:
28314987
39.

Optic nerve head microcirculation in autosomal dominant optic atrophy and normal-tension glaucoma.

Himori N, Kunikata H, Inoue M, Takeshita T, Nishiguchi KM, Nakazawa T.

Acta Ophthalmol. 2017 Dec;95(8):e799-e800. doi: 10.1111/aos.13353. Epub 2017 Jan 30. No abstract available.

40.

The neuroprotective effect of latanoprost acts via klotho-mediated suppression of calpain activation after optic nerve transection.

Yamamoto K, Sato K, Yukita M, Yasuda M, Omodaka K, Ryu M, Fujita K, Nishiguchi KM, Machida S, Nakazawa T.

J Neurochem. 2017 Feb;140(3):495-508. doi: 10.1111/jnc.13902. Epub 2016 Dec 27.

41.

Analysis of Macular Drusen and Blood Test Results in 945 Macaca fascicularis.

Nishiguchi KM, Yokoyama Y, Fujii Y, Fujita K, Tomiyama Y, Kawasaki R, Furukawa T, Ono F, Shimozawa N, Togo M, Suzuki M, Nakazawa T.

PLoS One. 2016 Oct 24;11(10):e0164899. doi: 10.1371/journal.pone.0164899. eCollection 2016.

42.

The reduction of temporal optic nerve head microcirculation in autosomal dominant optic atrophy.

Inoue M, Himori N, Kunikata H, Takeshita T, Aizawa N, Shiga Y, Omodaka K, Nishiguchi KM, Takahashi H, Nakazawa T.

Acta Ophthalmol. 2016 Nov;94(7):e580-e585. doi: 10.1111/aos.12999. Epub 2016 Mar 3.

43.

Inhibitory Effects of Vegetable Juices on CYP3A4 Activity in Recombinant CYP3A4 and LS180 Cells.

Tsujimoto M, Uchida T, Kozakai H, Yamamoto S, Minegaki T, Nishiguchi K.

Biol Pharm Bull. 2016;39(9):1482-7. doi: 10.1248/bpb.b16-00263.

44.

Transcriptome profiling of the rat retina after optic nerve transection.

Yasuda M, Tanaka Y, Omodaka K, Nishiguchi KM, Nakamura O, Tsuda S, Nakazawa T.

Sci Rep. 2016 Jun 29;6:28736. doi: 10.1038/srep28736.

45.

Brimonidine Enhances the Electrophysiological Response of Retinal Ganglion Cells through the Trk-MAPK/ERK and PI3K Pathways in Axotomized Eyes.

Yukita M, Omodaka K, Machida S, Yasuda M, Sato K, Maruyama K, Nishiguchi KM, Nakazawa T.

Curr Eye Res. 2017 Jan;42(1):125-133. doi: 10.3109/02713683.2016.1153112. Epub 2016 Jun 17.

PMID:
27314704
46.

Measurement of Electroretinograms and Visually Evoked Potentials in Awake Moving Mice.

Tomiyama Y, Fujita K, Nishiguchi KM, Tokashiki N, Daigaku R, Tabata K, Sugano E, Tomita H, Nakazawa T.

PLoS One. 2016 Jun 3;11(6):e0156927. doi: 10.1371/journal.pone.0156927. eCollection 2016.

47.

The relationship between advanced glycation end products and ocular circulation in type 2 diabetes.

Hashimoto K, Kunikata H, Yasuda M, Ito A, Aizawa N, Sawada S, Kondo K, Satake C, Takano Y, Nishiguchi KM, Katagiri H, Nakazawa T.

J Diabetes Complications. 2016 Sep-Oct;30(7):1371-7. doi: 10.1016/j.jdiacomp.2016.04.024. Epub 2016 May 4.

PMID:
27209548
48.

Correction: Exome Sequencing of Index Patients with Retinal Dystrophies as a Tool for Molecular Diagnosis.

Corton M, Nishiguchi KM, Avila-Fernández A, Nikopoulos K, Riveiro-Alvarez R, Tatu SD, Ayuso C, Rivolta C.

PLoS One. 2016 Mar 31;11(3):e0153121. doi: 10.1371/journal.pone.0153121. eCollection 2016. No abstract available.

49.

Axial Spondylometaphyseal Dysplasia Is Caused by C21orf2 Mutations.

Wang Z, Iida A, Miyake N, Nishiguchi KM, Fujita K, Nakazawa T, Alswaid A, Albalwi MA, Kim OH, Cho TJ, Lim GY, Isidor B, David A, Rustad CF, Merckoll E, Westvik J, Stattin EL, Grigelioniene G, Kou I, Nakajima M, Ohashi H, Smithson S, Matsumoto N, Nishimura G, Ikegawa S.

PLoS One. 2016 Mar 14;11(3):e0150555. doi: 10.1371/journal.pone.0150555. eCollection 2016.

50.

Topical ocular dexamethasone decreases intraocular pressure and body weight in rats.

Sato K, Nishiguchi KM, Maruyama K, Moritoh S, Fujita K, Ikuta Y, Kasai H, Nakazawa T.

J Negat Results Biomed. 2016 Mar 12;15:5. doi: 10.1186/s12952-016-0048-x.

Supplemental Content

Loading ...
Support Center